Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes.
AYA
Acute myeloid leukemia
adolescents and young adults
allogeneic hematopoietic cell transplantation
leukemia treatment
Journal
Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
pubmed:
25
8
2022
medline:
21
12
2022
entrez:
24
8
2022
Statut:
ppublish
Résumé
Opposing acute lymphoblastic leukemia, sparse data about AYAs with acute myeloid leukemia (AML) is available. Overall, 125 AYAs (age 10-35 years) treated during the last two decades were evaluated and compared to 385 older patients. CBF leukemia was more frequent in AYAs (21.6% vs. 8%,
Identifiants
pubmed: 36002396
doi: 10.1080/10428194.2022.2113527
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM